RecruitMe Clinical Trial

The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking: A randomized, controlled trial
Medication-Assisted Therapeutic Treatment Research for Alcohol Use
Sponsor:NIAAA
Enrolling:Male and Female Patients
Study Length:12 Weeks
Age Range:Between 21 and 70 years old
IRB Number:7889
U.S. Government ID:NCT04084860
Contact: HOPE Clinic: 888.497.8427 / dakwarlab@nyspi.columbia.edu
Additional Study Information:

This 12-week free and confidential outpatient study is recruiting healthy adults who are currently seeking treatment for alcohol use. Participants will engage in twice-weekly clinic visits during which they will meet with a physician and complete measures with research assistants. Participants will also receive innovative, investigative medications twice throughout this trial (Weeks 2 and 5) to help facilitate their engagement in treatment. Upon completion of the study, participants will be referred to appropriate community providers to ensure that they have the necessary means to continue their progress. This study is being conducted at the Columbia University Irving Medical Center Department of Psychiatry.

Do You Qualify?
Is alcohol a problem for you?YesNo
Are you seeking treatment for your alcohol use?YesNo
Submit
Cancel
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
HOPE Clinic
Email: dakwarlab@nyspi.columbia.edu
Phone: 888.497.8427